Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Teng Y, Yang Z, Peng Y, Yang Y, Chen S, Li J, Gao D, Sun W, Wu Z, Zhou Y, Li X, Qi X. Endoplasmic Reticulum Stress Nano-Orchestrators for Precisely Regulated Immunogenic Cell Death as Potent Cancer Vaccines. Adv Healthc Mater 2025;14:e2401851. [PMID: 39449212 DOI: 10.1002/adhm.202401851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2024] [Revised: 10/14/2024] [Indexed: 10/26/2024]

For:	Teng Y, Yang Z, Peng Y, Yang Y, Chen S, Li J, Gao D, Sun W, Wu Z, Zhou Y, Li X, Qi X. Endoplasmic Reticulum Stress Nano-Orchestrators for Precisely Regulated Immunogenic Cell Death as Potent Cancer Vaccines. Adv Healthc Mater 2025;14:e2401851. [PMID: 39449212 DOI: 10.1002/adhm.202401851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2024] [Revised: 10/14/2024] [Indexed: 10/26/2024]

Number	Cited by Other Article(s)
1	Wu YY, Zhang KY, Huang JQ, Nie JM, Cheng H. An endoplasmic reticulum-targeting photodynamic AMPK agonist activates breast cancer immunotherapy through promoting immunogenic cell death and downregulation of PD-L1. Acta Pharmacol Sin 2025. [DOI: 10.1038/s41401-025-01583-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/19/2024] [Accepted: 05/07/2025] [Indexed: 06/09/2025] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse Collaborators Collapse

Number

Cited by Other Article(s)

Wu YY, Zhang KY, Huang JQ, Nie JM, Cheng H. An endoplasmic reticulum-targeting photodynamic AMPK agonist activates breast cancer immunotherapy through promoting immunogenic cell death and downregulation of PD-L1. Acta Pharmacol Sin 2025. [DOI: 10.1038/s41401-025-01583-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/19/2024] [Accepted: 05/07/2025] [Indexed: 06/09/2025]